125 related articles for article (PubMed ID: 1878678)
1. Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
Romeiras M; Rodrigues AS; Machado A; Jorge L; Nolasco I; Abecasis M
Bone Marrow Transplant; 1991; 7 Suppl 2():133. PubMed ID: 1878678
[No Abstract] [Full Text] [Related]
2. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
Spitzer TR; Cottler-Fox M; Torrisi J; Cahill R; Greenspan A; Lynch M; Deeg HJ
Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
[TBL] [Abstract][Full Text] [Related]
3. Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
Erer B; Angelucci E; Baronciani D; Tomasucci M; Giardini C; Gaziev J
Bone Marrow Transplant; 1993; 12 Suppl 1():93-5. PubMed ID: 8374576
[No Abstract] [Full Text] [Related]
4. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body irradiation for bone marrow transplantation].
Di Pietrantonj F; Proietti A; Capirci C
Radiol Med; 1984 Jun; 70(6):396-410. PubMed ID: 6398469
[TBL] [Abstract][Full Text] [Related]
6. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation.
Giorgiani G; Bozzola M; Cisternino M; Locatelli F; Gambarana D; Bonetti F; Zecca M; Lorini R; Severi F
Bone Marrow Transplant; 1991; 8 Suppl 1():53. PubMed ID: 1760641
[No Abstract] [Full Text] [Related]
7. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
8. The development of busulfan/cyclophosphamide preparative regimens.
Santos GW
Semin Oncol; 1993 Aug; 20(4 Suppl 4):12-6; quiz 17. PubMed ID: 8342070
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
[TBL] [Abstract][Full Text] [Related]
10. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia.
Wachowiak J; Bettoni C; Lange A; Malicki J; Kaczmarek-Kanold M; Głuszak B; Suchnicki K; Daszkiewicz P; Ebell W
Acta Haematol Pol; 1995; 26(4):377-84. PubMed ID: 8571739
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
Carpenter PA; Marshall GM; Giri N; Vowels MR; Russell SJ
Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
[TBL] [Abstract][Full Text] [Related]
13. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
Thomas AE; Patterson J; Prentice HG; Brenner MK; Ganczakowski M; Hancock JF; Pattinson JK; Blacklock HA; Hopewell JP
Bone Marrow Transplant; 1987 Apr; 1(4):347-55. PubMed ID: 3139113
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Kanfer EJ; Buckner CD; Fefer A; Storb R; Appelbaum FR; Hill RS; Amos D; Doney KC; Clift RA; Shulman HM
Bone Marrow Transplant; 1987 Apr; 1(4):339-46. PubMed ID: 3332142
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
16. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
Kalaycioglu ME; Bolwell BJ
Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
[TBL] [Abstract][Full Text] [Related]
18. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
[TBL] [Abstract][Full Text] [Related]
19. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
Tutschka PJ
Bone Marrow Transplant; 1993; 12 Suppl 1():34-6. PubMed ID: 8374557
[No Abstract] [Full Text] [Related]
20. Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
Tutschka PJ; Copelan EA; Kapoor N
Transplant Proc; 1989 Feb; 21(1 Pt 3):2952-4. PubMed ID: 2650402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
